Skip to content

Author

D. Slavkov

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

HEMATOLOGIC BIOMARKERS AS PREDICTORS OF IMMUNE-RELATED CUTANEOUS ADVERSE EVENTS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

Purpose: The study aimed to evaluate the association between baseline hematologic parameters and the development of immune-related cutaneous adverse events (irCAEs) in patients treated with immune checkpoint inhibitors (ICIs). Identifying predictive biomarkers for cutaneous toxicity is essential for early risk stratifi...

Svetoslava Troynaova-Slavkova, Preslav Vasilev, D. Slavkov et al. · 0 citations
Review Sep 2026

Advanced optical microscopy for skin imaging: from confocal to novel techniques.

Timely and accurate diagnosis of dermatological diseases remains a global challenge, particularly in healthcare systems with limited access to dermatopathology services. Advanced optical microscopy techniques have emerged as powerful tools for non-invasive skin imaging, offering real-time visualization of microscopic s...

S. Troyanova-Slavkova, D. Slavkov, Preslav Vasilev et al. · 0 citations
Review Open access Oct 2026

Immunotherapy in Glioblastoma: Why Has Progress Been so Difficult?

This review summarizes the main immunotherapeutic approaches currently investigated, including immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and oncolytic viruses, and examines the key biological factors responsible for treatment resistance.

D. Slavkov, S. Troyanova-Slavkova · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.